Antiviral Effects of ABMA against Herpes Simplex Virus Type 2 In Vitro and In Vivo - Archive ouverte HAL Access content directly
Journal Articles Viruses Year : 2018

Antiviral Effects of ABMA against Herpes Simplex Virus Type 2 In Vitro and In Vivo

(1) , (2) , (1) , (1) , (1) , (1) , (2) , (2) , (1) , (2) , (1) , (1)
1
2
Wenwen Dai
  • Function : Author
  • PersonId : 1062436
Jinpeng Bi
  • Function : Author
Shuai Wang
Fang Li
  • Function : Author
Wei Kong
  • Function : Author
  • PersonId : 1062437
Feng Gao
Weiheng Su
  • Function : Author
  • PersonId : 1062438
Chunlai Jiang
  • Function : Author
  • PersonId : 1062439

Abstract

Herpes simplex virus type 2 (HSV-2) is the causative pathogen of genital herpes and is closely associated with the occurrence of cervical cancer and human immunodeficiency virus (HIV) infection. The absence of an effective vaccine and the emergence of drug resistance to commonly used nucleoside analogs emphasize the urgent need for alternative antivirals against HSV-2. Recently, ABMA [1-adamantyl (5-bromo-2-methoxybenzyl) amine] has been demonstrated to be an inhibitor of several pathogens exploiting host-vesicle transport, which also participates in the HSV-2 lifecycle. Here, we showed that ABMA inhibited HSV-2-induced cytopathic effects and plaque formation with 50% effective concentrations of 1.66 and 1.08 µM, respectively. We also preliminarily demonstrated in a time of compound addition assay that ABMA exerted a dual antiviral mechanism by impairing virus entry, as well as the late stages of the HSV-2 lifecycle. Furthermore, in vivo studies showed that ABMA protected BALB/c mice from intravaginal HSV-2 challenge with an improved survival rate of 50% at 5 mg/kg (8.33% for the untreated virus infected control). Consequently, our study has identified ABMA as an effective inhibitor of HSV-2, both in vitro and in vivo, for the first time and presents an alternative to nucleoside analogs for HSV-2 infection treatment.
Fichier principal
Vignette du fichier
29. Dai viruses-10-00119.pdf (5.36 Mo) Télécharger le fichier
Origin : Files produced by the author(s)
Loading...

Dates and versions

cea-02432376 , version 1 (08-01-2020)

Identifiers

Cite

Wenwen Dai, Yu Wu, Jinpeng Bi, Shuai Wang, Fang Li, et al.. Antiviral Effects of ABMA against Herpes Simplex Virus Type 2 In Vitro and In Vivo. Viruses, 2018, 10 (3), pp.119. ⟨10.3390/v10030119⟩. ⟨cea-02432376⟩
52 View
237 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More